£107.71

Humana STAT Inhibitors in Cancer - Drug Discovery & Development

Name: Humana STAT Inhibitors in Cancer - Drug Discovery & Development
Brand: Humana
Price: 107.71 GBP
Availability: InStock

Oncology

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£108 today · all-time low £107 (May 2026) · usually £108

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 84 days • 84 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 84 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £108 (46 days, 54.8%)

Price range: £107 - £114

Price levels: 4 different prices over 84 days

Description

STAT Inhibitors in Cancer (Cancer Drug Discovery and Development) provides a comprehensive look at the biological and clinical aspects of STAT inhibitors. This volume features contributions from leading scientists and clinicians, offering state-of-the-art information for professionals in the oncology field. Readers will gain a deep understanding of the biology of the STAT family of transcription factors and their specific roles in cancer etiology. The text covers a wide range of therapeutic approaches currently being used to inhibit STATs across various cancer types. By presenting emerging data from recent clinical trials, this book serves as a vital resource for those studying the full spectrum of therapeutic developments in cancer research and drug development.

Key Features

Includes expert contributions from leading scientists and clinicians to provide state-of-the-art information in the field of cancer research.

Offers a detailed overview of the biology of the STAT family of transcription factors and their role in cancer etiology.

Covers the full spectrum of therapeutic approaches used to inhibit STATs within the context of various cancers.

Provides access to emerging data from clinical trials regarding the use of STAT inhibitors.

Serves as a definitive resource for understanding the biological and clinical context of STAT inhibitors in cancer drug discovery.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 3319827014
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 16 June 2018
Listed Since: 18 June 2018

Barcode

No barcode data available

Humana STAT Inhibitors in Cancer - Drug Discovery & Development

About as cheap as it gets. The only time it was cheaper was 1 month ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Signal Transducers and Activators of Transcription (STATs): Activation and Biology

Statistical Thinking for Non-Statisticians in Drug Regulation

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Statistical Methods in Biomarker and Early Clinical Development

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Tumor Suppressor Genes: Volume 2: Regulation, Function, and Medicinal Applications: 223 (Methods in Molecular Biology, 223)

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

Advances in Cancer Research: Vol. 88: Volume 88

Topics in Biostatistics: 404 (Methods in Molecular Biology, 404)

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

Medical Statistics for Cancer Studies (Chapman & Hall/CRC Biostatistics Series)

Adverse Events and Oncotargeted Kinase Inhibitors

Recent Advances in Biostatistics: False Discovery Rates, Survival Analysis, and Related Topics (Series in Biostatistics): 4

Clinical Trial Biostatistics and Biopharmaceutical Applications

Presenting Medical Statistics from Proposal to Publication

Medical Statistics for Cancer Studies (Chapman & Hall/CRC Biostatistics Series)

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

The Long and Short Non-coding RNAs in Cancer Biology: 927 (Advances in Experimental Medicine and Biology, 927)

StataQuest 4 Windows 95 Version

Recent Advances in Clinical Trial Design and Analysis: 75 (Cancer Treatment and Research, 75)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Biomedical Informatics for Cancer Research

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)